Opexa Therapeutics, Inc. (OPXA) Reports Q3 Loss of $0.10
Tweet
Share
E-mailGet Alerts OPXA Hot Sheet
Price: $0.97 --0%
Financial Fact:
Other income and expense, net: -2.38K
Today's EPS Names:
TAYD, PKE, More
Financial Fact:
Other income and expense, net: -2.38K
Today's EPS Names:
TAYD, PKE, More
Join SI Premium – FREE
Opexa Therapeutics, Inc. (NASDAQ: OPXA) reported Q3 EPS of ($0.10), versus ($0.06) reported last year. Revenue for the quarter came in at $0 versus the consensus estimate of $0 .
For earnings history and earnings-related data on Opexa Therapeutics, Inc. (OPXA) click here.
For earnings history and earnings-related data on Opexa Therapeutics, Inc. (OPXA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rivian reports record Q3 deliveries, beats estimates, shares rise
- Robinhood shares climb on summit momentum and analyst support
- Freeport Q3 2026 copper output meets targets; gold sales deferred
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
